目的 加强药师对医生处方行为的干预,从而进一步规范医生处方行为。方法 通过查阅相关文献,回顾比较美国处方干预相关法律、教育培训、考核制度的优劣,结合我国体制和医务人员自身特点进行深度分析。结果 提出引入创新科技手段规范干预医师处方的临床路径,从而改善诊疗水平以及中国的就医环境。结论 提高药师自身专业素养,同时引入互联网模式和智能医疗等技术手段,提高临床、社区医疗机构以及社会药房的联动,提升互联网处方购药干预的可行性和可靠性,推动医药产业链的闭环连接和不断升级,逐步实现诊疗标准化模式、进而推动整体医疗水平的结果。
Abstract
OBJECTIVE To strengthen pharmacist intervention in prescribing behavior of doctors, so as to further standardize prescribing behavior.METHODS Through the review of the advantages and disadvantages of the relevant laws, education training and assessment system for prescription intervention in the USA, a deep analysis was made in combination with the Chinese system and the characteristics of the medical staff.RESULTS A new clinical pathway was introduced to standardize the intervention of doctors′ prescriptions, so as to improve the level of diagnosis and treatment and the environment for medical treatment in China.CONCLUSION Improving pharmacists′ professional accomplishment and introducing Internet model and intelligent medical technology can improve the linkage among clinical, community medical institutions and social pharmacies, and also enhance the feasibility and reliability of Internet prescription drug purchase intervention. Promote the closed-loop connection and continuous upgrading of the pharmaceutical industry chain, gradually realize the standardization model of diagnosis and treatment, and then promote the results of the overall medical level.
关键词
药学干预 /
处方干预 /
互联网模式 /
智能医疗 /
处方优化
{{custom_keyword}} /
Key words
pharmaceutical intervention /
prescription intervention /
internet mode /
intelligent medicine /
prescription optimization
{{custom_keyword}} /
中图分类号：
R951
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHEN J C. Standardization of prescription evaluation to improve rational drag use in medical institutions. J China Pharm(中国药房), 2009,20(28):2234-2236.
[2] SAIBAILAN. The Pharmacist Law has not yet been promulgated and the situation of pharmacists is awkward.. http://med.sina.cn/article_detail_103_1_42252.html.
[3] LI P, GE W H, LIANG Y. Current Situation of Clinical Pharmacists' Work in China from the Perspective of Literature Analysis . Chin Pharm J(中国药学杂志),2008,43(13):1 035.
[4] Drug Searcher. Apocalypse from American Pharmacists: The Million-Year Pay Way for Chinese Pharmacist..https://www.cn-healthcare.com/article/20171024/content-496612.html.
[5] NABP. Model Act . NABP,2017-08-01 . https://nabp.pharmacy/publications-reports/resource-documents/model-pharmacy-act-rules/.
[6] HU T X, LI Y Q. Brief Introduction to American Pharmacy Law(Ⅱ). Prog Pharm Sci(药学进展),1990,14(4):245-247.
[7] KEITH MO, SYLVIA AD, OLIVIA VN, et al. Clinical pharmacy education and practice in the United States. China Pharm, 2016, 27(2):145-149.
[8] ALAN HM, PAUL FS, LARRY NS, et al. Comprehensive Pharmacy Review Practice Exams. Vol 7. Pennsylvania:LWW,2008:5-25.
[9] American College of Clinical Pharmacy. Board of Regents commentary. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification. Pharmacotherapy . ACCP COMMENTARY, .https://www.accp.com/docs/positions/commentaries/commntry_BOR_DPC_phar1285.pdf.
[10] LU Y, YANG Y. Experience and Enlightenment of American Clinical Pharmacists in Developing Pharmaceutical Care. Herald Med,2006,(4):379-380.
[11] LIU Y C, SUN L H, SUN Q. Measures to Regulate Doctor's Prescription Behavior Abroad and Its Enlightenment to China. China Pharm(中国药业), 2010,19(24):9-10.
[12] LI Y P, HUANG Y M, SHAO R, et al. Comparison of licensed pharmacist examination between China and USA. Prog Pharm Sci(药学进展), 2007,31(1):42-45.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(4866 KB)
